Ivana A. Souza

Calgary, AB T2N4N1, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 46 publications

Gating effects of a Cav2.3 calcium channel variant linked to developmental and epileptic encephalopathy.

Gating effects of a Cav2.3 calcium channel variant linked to developmental and epileptic encephalopathy.

Journal: Neuroscience

Published: May 10, 2026

Characterization of Three Distinct Loss-of-Function Cav2.3 Variants.

Characterization of Three Distinct Loss-of-Function Cav2.3 Variants.

Journal: International journal of molecular sciences

Published: March 18, 2026

CaV3.2 T-type calcium channels contribute to CGRP- induced allodynia in a rodent model of experimental migraine.

CaV3.2 T-type calcium channels contribute to CGRP- induced allodynia in a rodent model of experimental migraine.

Journal: The journal of headache and pain

Published: October 29, 2024

A pathological missense mutation in the deubiquitinase USP5 leads to insensitivity to pain.

A pathological missense mutation in the deubiquitinase USP5 leads to insensitivity to pain.

Journal: The Journal of experimental medicine

Published: October 10, 2024

Determinants of interactions of a novel next-generation gabapentinoid NVA1309 and mirogabalin with the Cavα2δ-1 subunit.

Determinants of interactions of a novel next-generation gabapentinoid NVA1309 and mirogabalin with the Cavα2δ-1 subunit.

Journal: Molecular brain

Published: July 09, 2024

Contribution of T-type calcium channel isoforms to cold and mechanical sensitivity in naïve and oxaliplatin-treated mice of both sexes.

Contribution of T-type calcium channel isoforms to cold and mechanical sensitivity in naïve and oxaliplatin-treated mice of both sexes.

Journal: British journal of pharmacology

Published: June 18, 2024

A next generation peripherally restricted Cavα2δ-1 ligand with inhibitory action on Cav2.2 channels and utility in neuropathic pain.

A next generation peripherally restricted Cavα2δ-1 ligand with inhibitory action on Cav2.2 channels and utility in neuropathic pain.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: October 09, 2023

Electrophysiological and computational analysis of Cav3.2 channel variants associated with familial trigeminal neuralgia.

Electrophysiological and computational analysis of Cav3.2 channel variants associated with familial trigeminal neuralgia.

Journal: Molecular brain

Published: October 12, 2022

Regulation of N-type calcium channels by nociceptin receptors and its possible role in neurological disorders.

Regulation of N-type calcium channels by nociceptin receptors and its possible role in neurological disorders.

Journal: Molecular brain

Published: October 11, 2022

Differential regulation of Cav 3.2 and Cav 2.2 calcium channels by CB1 receptors and cannabidiol.

Differential regulation of Cav 3.2 and Cav 2.2 calcium channels by CB1 receptors and cannabidiol.

Journal: British journal of pharmacology

Published: September 07, 2022

Ca V 3.2 calcium channels contribute to trigeminal neuralgia.

Ca V 3.2 calcium channels contribute to trigeminal neuralgia.

Journal: Pain

Published: November 17, 2021

Correction to: Regulation of CaV3.2 channels by the receptor for activated C kinase 1 (Rack-1).

Correction to: Regulation of CaV3.2 channels by the receptor for activated C kinase 1 (Rack-1).

Journal: Pflugers Archiv : European journal of physiology

Published: October 21, 2021

Showing 1-12 of 46

Last Updated: 09/26/2026